Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Item No. 35718

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
S,S-hydroxy Bupropion is an active metabolite of the antidepressant bupropion.1,2 It is formed from bupropion by the cytochrome P450 (CYP) isoform CYP2B6.3 S,S-hydroxy Bupropion inhibits dopamine and norepinephrine but not serotonin (5-HT) reuptake in HEK293 cells expressing the human transporters (IC50s = 0.63, 0.241, and >100 µM, respectively).1 It is also an antagonist of α3β4-, α4β2-, α4β4-, and α1β1 subunit-containing nicotinic acetylcholine receptors (nAChRs; IC50s = 11, 3.3, 30, and 28 µM, respectively). S,S-hydroxy Bupropion inhibits nicotine-induced analgesia in the tail-flick and hot plate tests, hyperlocomotion, and hypothermia in mice (ED50s = 0.2, 1, 0.9, and 1.5 mg/kg, respectively). It substitutes for (+)-amphetamine in rats in a two-lever drug discrimination test (ED50 = 4.4 mg/kg).2
WARNING This product is not for human or veterinary use.
1. Synthesis and characterization of in vitro and in vivo profiles of hydroxybupropion analogues: Aids to smoking cessation. J. Med. Chem. 53(12), 4731-4748 (2010).
2. Behavioral and biochemical investigations of bupropion metabolites. Eur. J. Pharmacol. 474(1), 85-93 (2003).
3. Stereoselective metabolism of bupropion by cytochrome P4502B6 (CYP2B6) and human liver microsomes. Pharm. Res. 25(6), 1405-1411 (2008).